Company Snapshot: SCIO  Print This Story  Email This Story  Save this Link View PR Newswire's RSS Feed  Blogs Discussing this News Release  Search Blogs that Mention this News Release  Click this link to view linked Bookmarking Services Click this link to view linked Blogging Services


Scios Announces Presentation at the Needham & Company First Annual Biotechnology Conference

    SUNNYVALE, Calif., May 31 /PRNewswire-FirstCall/ --
Scios Inc. (Nasdaq: SCIO) announced that David W. Gryska, Senior Vice
President of Finance and Chief Financial Officer, and Thomas L. Feldman,
Vice President of Sales & Marketing, will present at the Needham & Company
First Annual Biotechnology Conference in New York City at 10:00 a.m. (EDT) on
Tuesday, June 4th, 2002.
    The presentation will be available via live webcast by accessing the
Needham & Company website located at
http://www.needhamco.com/Conferences/conferences.html or the Scios website
located at http://www.sciosinc.com.  To listen, viewers are encouraged to
visit the website at least fifteen minutes prior to the beginning of the
scheduled presentation to register, download and install all necessary audio
software.

    Scios Inc.
    Scios is a biopharmaceutical company developing novel treatments for
cardiovascular and inflammatory disease.  The Company's disease-based
technology platform integrates expertise in protein biology with computational
and medicinal chemistry to identify novel targets and rationally design small
molecule compounds for large markets with unmet medical needs.



SOURCE Scios Inc.




Back to Topback to top

Related links:
  • http://www.sciosinc.com
    CONTACT:
    David Gryska of Scios Inc., +1-408-616 8303;
    or Jim Weiss of WeissCom Partners, Inc., +1-415-203-0328, for
    Scios Inc.